Literature DB >> 8097141

Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro.

J A Prezioso1, N Wang, L Duty, W D Bloomer, E Gorelik.   

Abstract

B16 melanoma sublines (B16-F10-BL6 and B16-F1) exhibited elevated adenosine 3',5'-cyclic monophosphate (cAMP) levels when cultured in Dulbecco's modified Eagle's medium (DMEM) in comparison to cells in RPMI-1640 medium. In parallel, cells cultured in DMEM had increased tyrosinase activity, melanization and dendrite formation, all markers of melanoma differentiation. Also, the proliferative rates of both cell lines were decreased by 80-85% when cultured in DMEM relative to cells maintained in RPMI-1640 medium. In these studies, elevated levels of the melanin precursors tyrosine (Tyr) and phenylalanine (Phe) found in DMEM were shown not to be solely responsible for the phenotypic changes observed with DMEM. Both BL6 and B16-F1 cell lines formed more experimental pulmonary tumor metastasis in syngeneic C57BL/6 mice when maintained in DMEM vs RPMI-1640 medium. Analysis of metastasis formation in nude mice with normal and depleted natural killer (NK) cell activity revealed that the enhanced lung colonizing capacity of the BL6 cells maintained in DMEM was independent of the function of T-cell or NK-cell-mediated immunity. A close association between metastatic ability of tested lines and the expression of the membrane-associated enzyme gamma-glutamyltranspeptidase (gamma-GTPase, EC 2.3.2.2) was observed. The highly metastatic BL6 cell line had 20-fold higher levels of gamma-GTPase activity than the weakly metastatic B16-F1 cell line. Both cell lines, when grown in DMEM, had elevated gamma-GTPase activity that paralleled augmentation of metastatic ability. The dramatic changes in lung-colonizing capacity of the variant B16 melanoma cells maintained in DMEM in contrast to those grown in RPMI-1640 medium may serve as a useful model in understanding certain steps involved in triggering cell differentiation as well as metastasis development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097141     DOI: 10.1007/bf00121169

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  41 in total

1.  Control of melanogenesis in mouse melanoma cells of varying metastatic potential.

Authors:  R M Niles; J S Makarski
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

2.  Cyclic adenosine 3',5'-monophosphate in the control of melanoma cell replication and differentiation.

Authors:  J W Kreider; M Rosenthal; N Lengle
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

3.  Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts.

Authors:  R Halaban; A B Lerner
Journal:  Exp Cell Res       Date:  1977-08       Impact factor: 3.905

4.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

5.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

6.  Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.

Authors:  E Gorelik; R H Wiltrout; K Okumura; S Habu; R B Herberman
Journal:  Int J Cancer       Date:  1982-07-15       Impact factor: 7.396

7.  Effects of theophylline treatment on mouse B-16 melanoma cells in vitro.

Authors:  C A Kolb; J M Mansfield
Journal:  Oncology       Date:  1980       Impact factor: 2.935

8.  Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.

Authors:  C Aubert; F Rougé; J R Galindo
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

9.  Selective modification of glutathione metabolism.

Authors:  A Meister
Journal:  Science       Date:  1983-04-29       Impact factor: 47.728

10.  Endocrine responsiveness in human melanocytes and melanoma cells in culture.

Authors:  B B Fuller; F L Meyskens
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

View more
  8 in total

Review 1.  L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Authors:  Andrzej Slominski; Michal A Zmijewski; John Pawelek
Journal:  Pigment Cell Melanoma Res       Date:  2011-09-02       Impact factor: 4.693

2.  Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

Review 3.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

4.  Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.

Authors:  T Palomares; A Alonso-Varona; A Alvarez; B Castro; Y Calle; P Bilbao
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  PhosphoMARCKS drives motility of mouse melanoma cells.

Authors:  Xiangyu Chen; Susan A Rotenberg
Journal:  Cell Signal       Date:  2010-03-06       Impact factor: 4.315

6.  Angiogenic capacity and lung-colonizing potential in vivo is increased in weakly metastatic B16F1 cells and decreased in highly metastatic BL6 cells by phorbol esters.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

7.  Experimental metastasis and differentiation of murine melanoma cells: actions and interactions of factors affecting different intracellular signalling pathways.

Authors:  D C Bennett; A Holmes; L Devlin; I R Hart
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

Review 8.  Role of glutathione in cancer progression and chemoresistance.

Authors:  Nicola Traverso; Roberta Ricciarelli; Mariapaola Nitti; Barbara Marengo; Anna Lisa Furfaro; Maria Adelaide Pronzato; Umberto Maria Marinari; Cinzia Domenicotti
Journal:  Oxid Med Cell Longev       Date:  2013-05-20       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.